Zenas BioPharma (ZBIO) Cash from Operations (2023 - 2026)

Zenas BioPharma's Cash from Operations history runs 4 years deep, the most recent figure standing at 75196000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 102.95% year-over-year to 75196000.0; the TTM figure through Mar 2026 stood at 210478000.0 (down 52.94% YoY), while the FY2025 annual figure was 172333000.0, down 44.0% from the prior year.
• Cash from Operations was 75196000.0 for Q1 2026 at Zenas BioPharma, down from 52414000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 15400000.0 in Q4 2023 to a low of 75196000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 38260300.0 across 4 years, with a median of 37802500.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations tumbled 150.35% in 2024, then slumped 32.41% in 2025.
• A 4-year view of Cash from Operations shows it stood at 15400000.0 in 2023, then slumped by 150.35% to 38554000.0 in 2024, then slumped by 35.95% to 52414000.0 in 2025, then slumped by 43.47% to 75196000.0 in 2026.
• The last three Cash from Operations figures came in at 75196000.0 (Q1 2026), 52414000.0 (Q4 2025), and 41125000.0 (Q3 2025), per Business Quant data.